<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/ADC59AFE-2986-4C0D-94F5-7E04B66E9AF9"><gtr:id>ADC59AFE-2986-4C0D-94F5-7E04B66E9AF9</gtr:id><gtr:name>Curie Institute Paris (Institut Curie)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/CB597297-71EC-49CA-868E-47371DFC4207"><gtr:id>CB597297-71EC-49CA-868E-47371DFC4207</gtr:id><gtr:name>Oxford Radcliffe Hospitals NHS Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Sir William Dunn Sch of Pathology</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/ADC59AFE-2986-4C0D-94F5-7E04B66E9AF9"><gtr:id>ADC59AFE-2986-4C0D-94F5-7E04B66E9AF9</gtr:id><gtr:name>Curie Institute Paris (Institut Curie)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/CB597297-71EC-49CA-868E-47371DFC4207"><gtr:id>CB597297-71EC-49CA-868E-47371DFC4207</gtr:id><gtr:name>Oxford Radcliffe Hospitals NHS Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/0E54CDBB-3AF2-427A-B5F7-613BC9ED1BCB"><gtr:id>0E54CDBB-3AF2-427A-B5F7-613BC9ED1BCB</gtr:id><gtr:firstName>Natalia</gtr:firstName><gtr:surname>Gromak</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=MR%2FJ007870%2F1"><gtr:id>DBB2EF2C-A535-43A2-AD27-8C77483B718E</gtr:id><gtr:title>RNA metabolism in pathology of AOA2/ALS4 neurodegenerative disorders</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/J007870/1</gtr:grantReference><gtr:abstractText>All living organisms contain genetic information in a form of genes, which code for proteins - key building blocks of life. During the process of gene expression information from the gene, encoded in a DNA sequence is transferred into messenger RNA (transcription) followed by removal of non-coding intervening sequences (splicing), and decoding of this molecule into protein (translation). Each gene expression step is subjected to multiple regulatory events ensuring that the final protein product is correct. Now it became clear that key regulatory elements in gene expression are represented by the RNA. In this research project we will investigate the mechanism underlying the pathology of ataxia oculomotor apraxia type 2 (AOA2) and amyotrophic lateral sclerosis type 4 (ALS4), highly disabling inherited disorders, characterized by degeneration in the brain and spinal cord, causing progressive muscle weakness and finally atrophy. The gene mutated in these diseases encodes a protein called senataxin. Since the discovery of AOA2/ALS4 mutations in 2004, little progress has been made to characterize the function of senataxin protein or molecular mechanisms of AOA2/ALS4 pathology.
To study the function of senataxin protein in human cells, we will combine our expertise in RNA field with cutting edge high throughput technology in gene expression. In particular, we will perform experiments in human cells, which lack senataxin or were derived from patients' tissues. We hypothesise that AOA2/ALS4 pathologies arise due to defects in senataxin function associated with resolving connections between RNA and DNA, appearing during the process of transcription. If RNA/DNA molecules are not resolved properly, their accumulation can be detrimental to the cells causing pathologies. Initially, we will characterise the defects in transcription and RNA processing observed in cells with senataxin mutations using modern technologies analysing whole cell genome. We will also determine if RNA/DNA profile is perturbed in AOA2/ALS4 patients, and how it contributes to neurodegeneration. Furthermore, we will investigate the role of senataxin in transcription and RNA splicing. We will also identify new senataxin-interacting partners and study their contribution towards gene expression process and AOA2/ALS4 pathology.
Our project focuses on the function of senataxin, providing molecular clues for the pathology of AOA2/ALS4 diseases. It's becoming apparent that RNA processing may represent a common pathogenic mechanism involved in many neurodegenerative disorders. Around 50% of all characterised human genetic diseases are associated with inappropriate transcription/RNA processing. This emphasises the importance of fundamental molecular biology approach of our research towards understanding AOA2/ALS4 pathology. Therefore, the development of novel RNA-based therapies, improving the health and quality of life of AOA2/ALS4 and other neurodegenerative patients with defects of RNA processing, is a likely prospect of our research.</gtr:abstractText><gtr:technicalSummary>Ataxia oculomotor apraxia type 2 (AOA2) and amyotrophic lateral sclerosis type 4 (ALS4), are highly disabling disorders, characterised by neurodegeneration in the brain and spinal cord, causing progressive muscle weakness and finally atrophy, arising due to mutations in human senataxin protein. Senataxin shares homology with the yeast RNA/DNA helicase Sen1p and it has been suggested that senataxin may be involved in the regulation of gene expression. This research project will uncover molecular function of human senataxin protein using a combination of our expertise in RNA field and the cutting edge high throughput technology. In the first part of this project we will study transcriptional and RNA processing defects associated with AOA2/ALS4 mutations genome-wide. We propose that the function of senataxin in human cells is related to its RNA/DNA helicase function and its ability to unwind RNA/DNA hybrids (or R-loops) formed between nascent RNA transcripts and single stranded DNA template behind the elongating Pol II. We will investigate the effect of senataxin on genome-wide distribution of R-loops and study their contribution to the neurodegenerative phenotype, employing Solexa sequencing following DNA-immuno-precipitation (DIP-seq). Secondly, we will define the molecular functions of R-loops and senataxin in splicing regulation. Finally,we will identify novel RNA and protein senataxin-interacting partners, using mass-spectrometry and iCLIP approach, followed by the study of their function in gene expression and AOA2/ALS4 pathology. The long term goal of our work is to create a foundation for the collaboration between basic and clinical science beneficial to therapeutic advancement of AOA2/ALS4 diseases and development of novel molecular therapies, improving the health and quality of patients' life.</gtr:technicalSummary><gtr:potentialImpactText>The outcome of this research project will be beneficial to all AOA2/ALS4 patients affected by mutations in senataxin protein and also to neurologists and clinical geneticists, directly involved in treating these patients. Since the discovery of senataxin mutations in 2004, little is known about genotype/phenotype correlation in AOA2/ALS4 patients, making the correct diagnosis of these diseases in hospital practice quite laborious and difficult. Our work will make a major contribution to this knowledge, making the strategy for diagnosis of these diseases more efficient. 
Development of any therapeutic treatments for AOA2/ALS4 patients bas been hampered by the lack of understanding of molecular role of senataxin protein in humans. This project will investigate the function of senataxin in human cells and therefore shed the light on the underlying pathology of AOA2 disease, which may ultimately provide new targets for therapeutic treatment. In the long term, we are hoping to have an impact on treatment practices of these diseases. 
Proposed research project will be instrumental in the initiation of public awareness of human genetic disease research and corresponding therapeutic approaches. In particular, during the NIRG, we intend to communicate about the AOA2/ALS4 diseases to patients and healthy individuals through our research publications, scientific presentations and outreach work with the help of University of Oxford and Ataxia UK, Motor Neuron Disease Association and National Ataxia Foundation charities. The results of this research project are likely to have a big impact on the national health, thus enhancing quality of life and health of patients.</gtr:potentialImpactText><gtr:fund><gtr:end>2017-04-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>437027</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oxford Radcliffe Hospitals NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Weatherall Institute of Molecular Medicine (WIMM)</gtr:department><gtr:description>Role of ATRX in R-loop biology</gtr:description><gtr:id>063CD77B-CF13-42E5-A811-E6299B395DBB</gtr:id><gtr:impact>We are currently performing experiments which are likely to contribute to a figure in a joint paper.</gtr:impact><gtr:partnerContribution>Our collaborators established the importance of R-loops in recruitment to ATRX protein</gtr:partnerContribution><gtr:piContribution>We are testing the role of R-loops in ATRX recruitment. In particular, we are carrying out DIP experiments in RNase H1 knock-down cells</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London (ICL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Clinical Sciences Centre</gtr:department><gtr:description>Collaboration on FRDA project</gtr:description><gtr:id>DC6D4753-AF1A-40B8-B26A-B38310308E26</gtr:id><gtr:impact>Currently we are preparing paper for PLOS Genetics, describing the results of our collaborative work</gtr:impact><gtr:partnerContribution>The whole project is driven by group in Imperial College London</gtr:partnerContribution><gtr:piContribution>We carried out nascent transcriptional analysis on FXN gene for this collaboration</gtr:piContribution><gtr:sector>Multiple</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Curie Institute Paris (Institut Curie)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Role of PRMT1 protein in R-loop biology</gtr:description><gtr:id>A249BA10-DF77-47C7-8F6C-877A21BEC721</gtr:id><gtr:impact>We are hoping to write a joint paper by the end of 2016</gtr:impact><gtr:partnerContribution>Our collaborators have generated PRMT1 KD cells and purified genomic DNA samples for us to do DIP experiments.</gtr:partnerContribution><gtr:piContribution>We are currently using DIP experiments to study the contribution of PRMT1 to R-loop biology in triple-negative cancer cell lines</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Identifying new molecular mechanisms of replication stress for cancer therapy</gtr:description><gtr:id>86E051F7-942B-45A3-B82C-199DA275AE5C</gtr:id><gtr:impact>Currently a joint papers is under review in Nature Communications journal.</gtr:impact><gtr:partnerContribution>This project is fully driven by our collaborators, we are contributing with the DIP technique established in our lab</gtr:partnerContribution><gtr:piContribution>We are carrying out DIP procedure following RAS -driven induction in human cells</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Royal Society Research Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>50AA6DD0-E823-45F4-A313-22E4DD5043AE</gtr:id><gtr:impact>Following my talk at this conference, i established new collaborations with people outside of my field

I learned a lot about research in other fields and established new collaborations</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation at International Ataxia Research Conference, 25-28 May 2015</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>51DE3794-759E-4AA4-ACB1-A5C74569DEA4</gtr:id><gtr:impact>My presentation stimulated establishment of collaborations

I have met a number of interesting researchers and exchanged scientific ideas.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>https://www.ataxia.org.uk/international-research-conference</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation at Oxford Ataxia Group meeting, University of Oxford</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>3ABD16A0-C5BB-4E60-865F-8E8E59C36296</gtr:id><gtr:impact>Presentation at Oxford Ataxia Group meeting. 
Title: Molecular function of human senataxin protein in pathology of AOA2/ALS4 diseases.

Exchange of scientific ideas</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>RNA UK 2016 conference</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>210CAEC4-340E-4416-A541-AF87015C9292</gtr:id><gtr:impact>Presentation entitled 'The R-loop interactome in Human Cells' at the RNA UK Conference, Windermere, UK (January 2016). This presentation resulted in exchange in scientific data and establishment of scientific collaborations.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited talk at the 'RNA meets DNA' conference in Baeza, Spain</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6A54E5DC-0491-4855-8F7D-047CE36D52CE</gtr:id><gtr:impact>I established a number of very interesting collaborations with international researches

I was able to share the results of my research with wider international community</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited departmental seminar at the Dunn School of Pathology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>A4CFDD4D-6286-4B80-B94E-311562873313</gtr:id><gtr:impact>I established new collaborations and received very good suggestions to carry out certain experiments

A number of students were interested in visiting my lab and carrying out their rotation projects with me</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science outreach for ataxia patients</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>571676D6-192D-43E9-A36A-F27C20E1C8DE</gtr:id><gtr:impact>Around 50 patients attended 2015 Ataxia UK Annual Conference&amp;quot; 2nd - 3rd October 2015 and my student Matthias Groh presented the poster at the &amp;quot;Meet the Researchers - 10 ataxia researchers discuss their work&amp;quot; session on the 3rd October. This presentation sparked the discussion with patients, and resulted in their better understanding of the ataxia and its underlying molecular mechanisms</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cold Spring Harbour, USA, RNA processing conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>AE0FD8D3-BDDD-4C51-80E7-53E60DDED452</gtr:id><gtr:impact>Poster presentation entitled 'The R-loop proteome in human cells'. My presentation sparked discussion with scientists working in the same field and as a result of this I started a couple of collaborations</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited at Hallmarks of cancer conference</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0B774608-859E-4FD8-AB8C-16D2657380A8</gtr:id><gtr:impact>Invited talk entitled ' The R-loop proteome uncovers novel links between genome instability and human disease' at the International symposium: Hallmarks of cancer: focus on RNA. Institute Curie, Paris, France (October 2015). My talk spackled a lot of scientific discussions and as a result of this presentation I established important collaboration.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Study participants or study members</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation at the Oxford Transcription Meeting</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>891326EC-509A-4AD9-AB75-07A9CE02C1F5</gtr:id><gtr:impact>Presentation entitled 'Transcriptional mis-regulation in neurodegenerative disorders' at the Oxford Transcription Meeting. The presentation resulted in exchange of scientific information with Oxford colleagues working in transcription field.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited seminar at the Institute of Neurology, University College London (UK).</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>B8F1220B-6EAC-464A-9E31-928B8F89B03E</gtr:id><gtr:impact>Departmental seminar at the Institute of Neurology, University College London (UK). 
Talk: RNA biology in neurodegeneration.

Establishment of collaborations. As a result of this seminar, i was asked to write a review on the topic of my seminar for PLOS Genetics journal</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at Oxford Ataxia Group Meeting, University of Oxford</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>CD8F71E3-7374-4CF8-8820-3A38A993B393</gtr:id><gtr:impact>Presentation at Oxford Ataxia Group Meeting.
Title: R-loops in transcriptional regulation of trinucleotide expansion diseases.

Exchange of scientific ideas</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecturing at Graduate GABBA course 'Regulation of Gene Expression', University of Porto (Portugal)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>608C7A60-E15B-4C51-AB58-D0E72A9367A7</gtr:id><gtr:impact>2010-2015 Graduate GABBA course 'Regulation of Gene Expression'. Delivering lectures and paper dissections to the 1st year PhD students in Molecular and Cell biology. University of Porto (Portugal).

Exposure of students from Portugal to cutting edge research in Gene expression.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2010,2011,2012,2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar  Department of Biochemistry, University of Cambridge</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>AAF782CD-EC54-4CA4-A075-D050529DAECC</gtr:id><gtr:impact>Invited Departmental seminar entitled: R-loops: unusual RNA/DNA structures and their role in health and disease' at the Department of Biochemistry, University of Cambridge. This seminar has allowed scientific discussions with people working in different fields and resulted in exchange of scientific reagents</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>551313</gtr:amountPounds><gtr:country>Denmark, Kingdom of</gtr:country><gtr:currCode>DKK</gtr:currCode><gtr:currCountryCode>Denmark</gtr:currCountryCode><gtr:currLang>da_DK</gtr:currLang><gtr:description>Lundbeck Foundation Fellowship</gtr:description><gtr:end>2015-11-02</gtr:end><gtr:fundingOrg>Lundbeck Foundation</gtr:fundingOrg><gtr:fundingRef>R126-2012-12263</gtr:fundingRef><gtr:id>F2D6EB7D-3EBB-4E4E-AFD2-A8A9BBCB3EBB</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Biochemical Society UK</gtr:description><gtr:end>2016-02-02</gtr:end><gtr:fundingOrg>Biochemical Society</gtr:fundingOrg><gtr:fundingRef>Conference grant to support RNA UK 2016 conference, where i was the main organiser</gtr:fundingRef><gtr:id>8627C03E-C187-4253-B214-9CA7E2BC85AD</gtr:id><gtr:sector>Learned Society</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>93958</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>John Fell Research Award</gtr:description><gtr:end>2016-10-02</gtr:end><gtr:fundingOrg>University of Oxford</gtr:fundingOrg><gtr:fundingRef>BVD07340</gtr:fundingRef><gtr:id>4FEA0E0C-B27F-47ED-A7C2-9DC1131D5274</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>14600</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>National Ataxia Foundation Research Pilot Grant</gtr:description><gtr:end>2010-10-02</gtr:end><gtr:fundingOrg>National Ataxia Foundation</gtr:fundingOrg><gtr:id>550FA67B-8669-40DB-A78C-B1FEAA2D284E</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>496345</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Royal Society University Research Fellowship</gtr:description><gtr:end>2016-10-02</gtr:end><gtr:fundingOrg>The Royal Society</gtr:fundingOrg><gtr:id>B51E3F10-F70B-4FC2-AC0B-D3C238BA5F57</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>14400</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Royal Society Research grant</gtr:description><gtr:end>2013-10-02</gtr:end><gtr:fundingOrg>The Royal Society</gtr:fundingOrg><gtr:id>D7C2E92C-1F69-44BA-A252-AFEF95E41D65</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/404961B1-695E-4D67-8D1D-6D551571EC6D"><gtr:id>404961B1-695E-4D67-8D1D-6D551571EC6D</gtr:id><gtr:title>Human R-loop interactome</gtr:title><gtr:parentPublicationTitle>under review</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8eb27be328607b862777b7aace00fe01"><gtr:id>8eb27be328607b862777b7aace00fe01</gtr:id><gtr:otherNames>Groh, M</gtr:otherNames></gtr:author></gtr:authors></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7112D3A1-6A01-48E7-A71E-7CBDF6F106A0"><gtr:id>7112D3A1-6A01-48E7-A71E-7CBDF6F106A0</gtr:id><gtr:title>Intronic microRNAs: a crossroad in gene regulation.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dd34dfa004c3496cb1acec2a9973da79"><gtr:id>dd34dfa004c3496cb1acec2a9973da79</gtr:id><gtr:otherNames>Gromak N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EE70250E-5D27-494E-8743-E6ADDF474848"><gtr:id>EE70250E-5D27-494E-8743-E6ADDF474848</gtr:id><gtr:title>Human senataxin resolves RNA/DNA hybrids formed at transcriptional pause sites to promote Xrn2-dependent termination.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f28436ba360749d61a82f9e9c7c6a227"><gtr:id>f28436ba360749d61a82f9e9c7c6a227</gtr:id><gtr:otherNames>Skourti-Stathaki K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/75EF4B1C-897A-430E-8752-A0B4BFDC70F6"><gtr:id>75EF4B1C-897A-430E-8752-A0B4BFDC70F6</gtr:id><gtr:title>Out of balance: R-loops in human disease.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/919fdf71ec1069dfdb37d5c85e88509b"><gtr:id>919fdf71ec1069dfdb37d5c85e88509b</gtr:id><gtr:otherNames>Groh M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6C1A8D82-399A-4726-9624-BE40AA22DFAA"><gtr:id>6C1A8D82-399A-4726-9624-BE40AA22DFAA</gtr:id><gtr:title>R-loops associated with triplet repeat expansions promote gene silencing in Friedreich ataxia and fragile X syndrome.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/919fdf71ec1069dfdb37d5c85e88509b"><gtr:id>919fdf71ec1069dfdb37d5c85e88509b</gtr:id><gtr:otherNames>Groh M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1BE5AC73-3738-4C99-941B-4308E306AFBC"><gtr:id>1BE5AC73-3738-4C99-941B-4308E306AFBC</gtr:id><gtr:title>Increased global transcription activity as a mechanism of replication stress in cancer.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/17271d853fe77659cf3d8963479c62f2"><gtr:id>17271d853fe77659cf3d8963479c62f2</gtr:id><gtr:otherNames>Kotsantis P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0FA77372-74DC-4252-BEBF-83F60E5E0F76"><gtr:id>0FA77372-74DC-4252-BEBF-83F60E5E0F76</gtr:id><gtr:title>Mechanisms of transcriptional dysregulation in repeat expansion disorders.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/919fdf71ec1069dfdb37d5c85e88509b"><gtr:id>919fdf71ec1069dfdb37d5c85e88509b</gtr:id><gtr:otherNames>Groh M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AF1E3052-A6A2-4C47-92B1-EAD35563C204"><gtr:id>AF1E3052-A6A2-4C47-92B1-EAD35563C204</gtr:id><gtr:title>Drosha regulates gene expression independently of RNA cleavage function.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dd34dfa004c3496cb1acec2a9973da79"><gtr:id>dd34dfa004c3496cb1acec2a9973da79</gtr:id><gtr:otherNames>Gromak N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/J007870/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>